Cargando…

Liver Fibrosis Regression and Associated Factors in HCV Patients Treated with Direct-Acting Antiviral Agents

There is accumulating evidence that treatment of chronic hepatitis C (HCV) leads to improvements in liver fibrosis. We aimed to investigate the improvement in fibrosis stage following treatment with direct-acting antivirals (DAAs) and factors associated with fibrosis regression. Fibroscan(®) was per...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abu-Freha, Naim, Abu-Kosh, Osama, Yardeni, David, Ashur, Yaffa, Abu-Arar, Muhammad, Yousef, Baha, Monitin, Shulamit, Weissmann, Sarah, Etzion, Ohad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533124/ https://www.ncbi.nlm.nih.gov/pubmed/37763276 http://dx.doi.org/10.3390/life13091872

Ejemplares similares

Comorbidities and Malignancy among NAFLD Patients Compared to the General Population, A Nation-Based Study
por: Abu-Freha, Naim, et al.
Publicado: (2023)

Indications and Findings of Upper Endoscopies in Males and Females, Are They the Same or Different?
por: Abu-Freha, Naim, et al.
Publicado: (2021)

Spontaneous Bacterial Peritonitis among Cirrhotic Patients: Prevalence, Clinical Characteristics, and Outcomes
por: Abu-Freha, Naim, et al.
Publicado: (2021)

Response guided therapy for reducing duration of direct acting antivirals in chronic hepatitis C infected patients: a Pilot study
por: Etzion, Ohad, et al.
Publicado: (2020)

Adherence to Anti-Viral Treatment for Chronic Hepatitis B
por: Abu-Freha, Naim, et al.
Publicado: (2020)

Chronic hepatitis C: Diagnosis and treatment made easy
por: Abu-Freha, Naim, et al.
Publicado: (2022)

ASCA and ANCA among Bedouin Arabs with inflammatory bowel disease, the frequency and phenotype correlation
por: Abu-Freha, Naim, et al.
Publicado: (2018)

Comorbidities and Outcomes among Females with Non-Alcoholic Fatty Liver Disease Compared to Males
por: Abu-Freha, Naim, et al.
Publicado: (2022)

The impact of the COVID-19 pandemic on colorectal and gastric cancer diagnosis, disease stage and mortality
por: Abu-Freha, Naim, et al.
Publicado: (2022)

Hepatitis C Elimination: Opportunities and Challenges in 2023
por: Taha, Gadeer, et al.
Publicado: (2023)

HIV/HCV Antiviral Drug Interactions in the Era of Direct-acting Antivirals
por: Rice, Donald P., et al.
Publicado: (2016)

Colorectal cancer among inflammatory bowel disease patients: risk factors and prevalence compared to the general population
por: Abu-Freha, Naim, et al.
Publicado: (2023)

Analysis of Effect of Antiviral Therapy on Regression of Liver Fibrosis in Patient with HCV Infection
por: Vukobrat-Bijedic, Zora, et al.
Publicado: (2014)

Ethnic Issues and Disparities in Inflammatory Bowel Diseases: What Can We Learn from the Arab Population in Israel?
por: Abu-Freha, Naim, et al.
Publicado: (2023)

Maternal Hepatitis B Virus or Hepatitis C Virus Carrier Status and Long-Term Endocrine Morbidity of the Offspring—A Population-Based Cohort Study
por: Abu Freha, Naim, et al.
Publicado: (2020)

HCV-Associated Nephropathies in the Era of Direct Acting Antiviral Agents
por: Angeletti, Andrea, et al.
Publicado: (2019)

The ‘Viennese epidemic’ of acute HCV in the era of direct‐acting antivirals
por: Chromy, David, et al.
Publicado: (2022)

Transplantation of HCV Viremic Livers into HCV Viremic Recipients Followed by Direct-acting Antiviral Therapy
por: Kapila, Nikhil, et al.
Publicado: (2019)

COVID-19 Vaccination Among the Arab Bedouin Population: Lessons Learned From a Minority Population
por: Abu-Freha, Naim, et al.
Publicado: (2022)

Regression of liver fibrosis and hepatocellular carcinoma development after HCV eradication with oral antiviral agents
por: Yoo, Hae Won, et al.
Publicado: (2022)

Survival of HIV/HCV co-infected patients before introduction of HCV direct acting antivirals (DAA)
por: Dold, L., et al.
Publicado: (2019)

HCV Cure With Direct-Acting Antivirals Improves Liver and Immunological Markers in HIV/HCV-Coinfected Patients
por: Brochado-Kith, Óscar, et al.
Publicado: (2021)

Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era
por: Stevenson, Heather L., et al.
Publicado: (2016)

Prioritization of HCV treatment in the direct-acting antiviral era: An economic evaluation
por: Martin, Natasha K., et al.
Publicado: (2016)

Telomere Length Increase in HIV/HCV-Coinfected Patients with Cirrhosis after HCV Eradication with Direct-Acting Antivirals (†)
por: Molina-Carrión, Silvia, et al.
Publicado: (2020)

Baseline Plasma Metabotype Correlates With Direct-Acting Antiviral Therapy Nonresponse for HCV in HIV–HCV Coinfected Patients
por: Tripathi, Gaurav, et al.
Publicado: (2022)

Genetic Barrier to Direct Acting Antivirals in HCV Sequences Deposited in the European Databank
por: Kliemann, Dimas Alexandre, et al.
Publicado: (2016)

HCV and kidney transplant in the era of new direct-acting antiviral agents (DAAs)
por: La Manna, Gaetano
Publicado: (2018)

Eradication of HCV Infection with the Direct-Acting Antiviral Therapy in Renal Allograft Recipients
por: Armando, Calogero, et al.
Publicado: (2019)

Direct-Acting Antiviral Agents for HCV-Associated Glomerular Disease and the Current Evidence
por: Fabrizi, Fabrizio, et al.
Publicado: (2019)

Real-world efficacy of direct acting antiviral therapies in patients with HIV/HCV
por: Patel, Sonia Vibhakar, et al.
Publicado: (2020)

Augmenting central arterial stiffness following eradication of HCV by direct acting antivirals in advanced fibrosis patients
por: Cheng, Pin-Nan, et al.
Publicado: (2019)

24-month decline of non-invasive liver fibrosis markers in HCV-mono and HCV/HIV coinfection after direct-acting antiviral therapy
por: Pérez-Is, Laura, et al.
Publicado: (2022)

356. HIV-HCV Coinfection: An Investigation of CD4 T-Cell Reconstitution after HCV Direct-Acting Antiviral Treatment
por: Michienzi, Sarah M, et al.
Publicado: (2019)

T-cell Activation Is Correlated With Monocyte Activation in HCV/HIV Coinfection and Declines During HCV Direct-Acting Antiviral Therapy
por: Auma, Ann W N, et al.
Publicado: (2021)

HIV tropism switch in archived DNA of HIV-HCV subjects successfully treated with direct-acting antivirals for HCV infection
por: Basso, Monica, et al.
Publicado: (2021)

Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination
por: Virlogeux, Victor, et al.
Publicado: (2017)

Erratum to “Eradication of HCV Infection with the Direct-Acting Antiviral Therapy in Renal Allograft Recipients”
por: Calogero, Armando, et al.
Publicado: (2019)

2223. Effect of Direct-Acting Antivirals in Hemodialysis Patients with HCV: Real-Life Data
por: Aydin, Nurten Nur, et al.
Publicado: (2018)

Direct‐acting antivirals ability to clear intestinal HCV‐RNA in liver transplant patients
por: Pietrosi, Giada, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g3o30tgdukg29f42pvvvu9e8v1